NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer

NCT06494514 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Pancreatic Cancer

Interventions

DRUG: nal-IRI+Oxaliplatin+5-FU/LV+PD-1
DRUG: Gemcitabine + albumin-paclitaxel+PD-1

Sponsor

Du Juan